1060 related articles for article (PubMed ID: 20032975)
1. The transcriptional network for mesenchymal transformation of brain tumours.
Carro MS; Lim WK; Alvarez MJ; Bollo RJ; Zhao X; Snyder EY; Sulman EP; Anne SL; Doetsch F; Colman H; Lasorella A; Aldape K; Califano A; Iavarone A
Nature; 2010 Jan; 463(7279):318-25. PubMed ID: 20032975
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-6 induces malignant transformation of rat mesenchymal stem cells in association with enhanced signaling of signal transducer and activator of transcription 3.
Cui X; Liu J; Bai L; Tian J; Zhu J
Cancer Sci; 2014 Jan; 105(1):64-71. PubMed ID: 24168060
[TBL] [Abstract][Full Text] [Related]
3. RTVP-1 promotes mesenchymal transformation of glioma via a STAT-3/IL-6-dependent positive feedback loop.
Giladi ND; Ziv-Av A; Lee HK; Finniss S; Cazacu S; Xiang C; Waldman Ben-Asher H; deCarvalho A; Mikkelsen T; Poisson L; Brodie C
Oncotarget; 2015 Sep; 6(26):22680-97. PubMed ID: 26267319
[TBL] [Abstract][Full Text] [Related]
4. Aberrant mesenchymal differentiation of glioma stem-like cells: implications for therapeutic targeting.
Balasubramaniyan V; Vaillant B; Wang S; Gumin J; Butalid ME; Sai K; Mukheef F; Kim SH; Boddeke HW; Lang F; Aldape K; Sulman EP; Bhat KP; Colman H
Oncotarget; 2015 Oct; 6(31):31007-17. PubMed ID: 26307681
[TBL] [Abstract][Full Text] [Related]
5. Transglutaminase 2 Inhibition Reverses Mesenchymal Transdifferentiation of Glioma Stem Cells by Regulating C/EBPβ Signaling.
Yin J; Oh YT; Kim JY; Kim SS; Choi E; Kim TH; Hong JH; Chang N; Cho HJ; Sa JK; Kim JC; Kwon HJ; Park S; Lin W; Nakano I; Gwak HS; Yoo H; Lee SH; Lee J; Kim JH; Kim SY; Nam DH; Park MJ; Park JB
Cancer Res; 2017 Sep; 77(18):4973-4984. PubMed ID: 28754668
[TBL] [Abstract][Full Text] [Related]
6. C6 glioma-conditioned medium induces malignant transformation of mesenchymal stem cells: Possible role of S100B/RAGE pathway.
Tan B; Shen L; Yang K; Huang D; Li X; Li Y; Zhao L; Chen J; Yi Q; Xu H; Tian J; Zhu J
Biochem Biophys Res Commun; 2018 Jan; 495(1):78-85. PubMed ID: 29050939
[TBL] [Abstract][Full Text] [Related]
7. CCAAT/enhancer binding protein beta (C/EBPbeta)-2 transforms normal mammary epithelial cells and induces epithelial to mesenchymal transition in culture.
Bundy LM; Sealy L
Oncogene; 2003 Feb; 22(6):869-83. PubMed ID: 12584567
[TBL] [Abstract][Full Text] [Related]
8. Glioma IL13Rα2 is associated with mesenchymal signature gene expression and poor patient prognosis.
Brown CE; Warden CD; Starr R; Deng X; Badie B; Yuan YC; Forman SJ; Barish ME
PLoS One; 2013; 8(10):e77769. PubMed ID: 24204956
[TBL] [Abstract][Full Text] [Related]
9. C/EBPβ mediates RNA polymerase III-driven transcription of oncomiR-138 in malignant gliomas.
Di Pascale F; Nama S; Muhuri M; Quah S; Ismail HM; Chan XHD; Sundaram GM; Ramalingam R; Burke B; Sampath P
Nucleic Acids Res; 2018 Jan; 46(1):336-349. PubMed ID: 29136251
[TBL] [Abstract][Full Text] [Related]
10. The landscape of the mesenchymal signature in brain tumours.
Behnan J; Finocchiaro G; Hanna G
Brain; 2019 Apr; 142(4):847-866. PubMed ID: 30946477
[TBL] [Abstract][Full Text] [Related]
11. RHPN2 drives mesenchymal transformation in malignant glioma by triggering RhoA activation.
Danussi C; Akavia UD; Niola F; Jovic A; Lasorella A; Pe'er D; Iavarone A
Cancer Res; 2013 Aug; 73(16):5140-50. PubMed ID: 23774217
[TBL] [Abstract][Full Text] [Related]
12. Molecular heterogeneity in a patient-derived glioblastoma xenoline is regulated by different cancer stem cell populations.
Garner JM; Ellison DW; Finkelstein D; Ganguly D; Du Z; Sims M; Yang CH; Interiano RB; Davidoff AM; Pfeffer LM
PLoS One; 2015; 10(5):e0125838. PubMed ID: 25955030
[TBL] [Abstract][Full Text] [Related]
13. Computational analysis of the mesenchymal signature landscape in gliomas.
Celiku O; Tandle A; Chung JY; Hewitt SM; Camphausen K; Shankavaram U
BMC Med Genomics; 2017 Mar; 10(1):13. PubMed ID: 28279210
[TBL] [Abstract][Full Text] [Related]
14. Exosomes from glioma cells induce a tumor-like phenotype in mesenchymal stem cells by activating glycolysis.
Ma Z; Cui X; Lu L; Chen G; Yang Y; Hu Y; Lu Y; Cao Z; Wang Y; Wang X
Stem Cell Res Ther; 2019 Feb; 10(1):60. PubMed ID: 30770778
[TBL] [Abstract][Full Text] [Related]
15. IL22 furthers malignant transformation of rat mesenchymal stem cells, possibly in association with IL22RA1/STAT3 signaling.
Cui X; Jing X; Yi Q; Xiang Z; Tian J; Tan B; Zhu J
Oncol Rep; 2019 Apr; 41(4):2148-2158. PubMed ID: 30816520
[TBL] [Abstract][Full Text] [Related]
16. Decreased CCAAT/enhancer binding protein β expression inhibits the growth of glioblastoma cells.
Aguilar-Morante D; Cortes-Canteli M; Sanz-Sancristobal M; Santos A; Perez-Castillo A
Neuroscience; 2011 Mar; 176():110-9. PubMed ID: 21185356
[TBL] [Abstract][Full Text] [Related]
17. Identification of a core miRNA-pathway regulatory network in glioma by therapeutically targeting miR-181d, miR-21, miR-23b, β-Catenin, CBP, and STAT3.
Li R; Li X; Ning S; Ye J; Han L; Kang C; Li X
PLoS One; 2014; 9(7):e101903. PubMed ID: 25007077
[TBL] [Abstract][Full Text] [Related]
18. The tumor microenvironment strongly impacts master transcriptional regulators and gene expression class of glioblastoma.
Cooper LA; Gutman DA; Chisolm C; Appin C; Kong J; Rong Y; Kurc T; Van Meir EG; Saltz JH; Moreno CS; Brat DJ
Am J Pathol; 2012 May; 180(5):2108-19. PubMed ID: 22440258
[TBL] [Abstract][Full Text] [Related]
19. Transformation of quiescent adult oligodendrocyte precursor cells into malignant glioma through a multistep reactivation process.
Galvao RP; Kasina A; McNeill RS; Harbin JE; Foreman O; Verhaak RG; Nishiyama A; Miller CR; Zong H
Proc Natl Acad Sci U S A; 2014 Oct; 111(40):E4214-23. PubMed ID: 25246577
[TBL] [Abstract][Full Text] [Related]
20. A novel drug conjugate, NEO212, targeting proneural and mesenchymal subtypes of patient-derived glioma cancer stem cells.
Jhaveri N; Agasse F; Armstrong D; Peng L; Commins D; Wang W; Rosenstein-Sisson R; Vaikari VP; Santiago SV; Santos T; Chen L; Schönthal AH; Chen TC; Hofman FM
Cancer Lett; 2016 Feb; 371(2):240-50. PubMed ID: 26683773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
